Here you will find the latest updates and news from Farmak International. Discover important announcements, breakthroughs in research, and developments in our ongoing commitment to advancing healthcare. Stay informed about our milestones as we continue to make a positive impact on global health.
Farmak International presented its sterile injectables portfolio, 100-year legacy, and new manufacturing capabilities in Spain at CPHI Worldwide 2025 in Frankfurt.
The World Health Organization (WHO) has confirmed continued prequalification status for Farmak Group’s dexamethasone (as sodium phosphate) injection following a routine requalification in March 2025.
In June 2025, Farmak International delivered vasopressin to Qatar in its first-ever export to the country, following a successful tender award.
At Farmak International, our purpose is simple yet ambitious: transform complex science into life-changing solutions.
Farmak International announced that its 10 mg immediate-release tofacitinib tablet met all European Medicines Agency (EMA) bioequivalence requirements, completing the clinical module needed for a generic application under Article 10(1).
Please check your email inbox for our corporate materials.
OK, Got ItPlease fill all the fields marked by *
